USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/5359
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTimercan, Tatiana
dc.date.accessioned2019-06-26T03:09:28Z
dc.date.available2019-06-26T03:09:28Z
dc.date.issued2018
dc.identifier.citationTimercan, Tatiana. Experimental myocadial infarction and Interleukine-6 modifications. In: MedEspera: the 7th International Medical Congress for Students and Young Doctors: abstract book. Chişinău: S. n., 2018 (Tipografia Editurii “Universul”), p. 200
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/5359
dc.descriptionDepartment of Biochemistry and Clinical Biochemistry Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldovaen_US
dc.description.abstractIntroduction. The inflammatory response, manifested as acute necrosis, is induced by ischemia in infracted myocardium. Myocardial remodelling is one of the complications, which leads to arrhythmias and heart failure. Interleukine-6 (IL-6) is a cytokine involved in tissue remodelling, as well as in the pro- and anti-inflammatory response pathways. Post infarct it promotes myocyte hypertrophy and myocardial dysfunction. In addition, IL-6 inhibits cardiomyocyte apoptosis. Aim of the study. To evaluate serum and homogenate IL-6 level in isoproterenol-induced acute myocardial infarction. Materials and methods. Forty adult male rats (Ratta albicans) were divided into five groups: L1 – intact (n=11); L2 – control animals which were administrated NaCl 0.9% (n=11); L3 (n=6), L4 (n=6) and L5 (n=6) included the animals with experimental myocardial infarction, reproduced by injecting subcutaneously isoproterenol hydrochloride 100 mg/kg (one dose). Rats were anesthetized, and sacrificed at 6h, 24h and 7 days respectively. For IL-6 assessment, we use standard Rat IL-6 ELISA kit (Beijing 4A Biotech Co. Ltd). The results were analyzed by Kruskal-Wallis nonparametric test using SPSS version 23. Discussion Results. The investigated groups have not presented any statistically significant difference neither in homogenate IL-6 content (p = 0.098), no in serum IL-6 level (p = 0,322). At the same time, higher amounts of both homogenate and serum IL-6 were registered in experimental groups compared to intact and control groups. Conclusions. Inflammation plays a significant role in the pathogenesis of myocardial ischemic injury. Infarcted myocardium increases the production of IL-6. Increased IL-6 levels for a prolonged time can indicate associated inflammation and elevated risk of second myocardial infarction. Serum IL-6 level following AMI can be used for the inflammatory process monitoring. In order to prove it the research should be enlarged, and statistical correlations will be performed.en_US
dc.language.isoenen_US
dc.publisherMedEspera 2018. The 7th International Medical Congress for Students and Young Doctors Abstract Booken_US
dc.subjectMyocardial Injuryen_US
dc.subjectInterleukine-6en_US
dc.subject.meshCytokinesen_US
dc.subject.meshInterleukinesen_US
dc.titleExperimental myocadial infarction and Interleukine-6 modificationsen_US
dc.typeArticleen_US
Appears in Collections:ARTICOLE ȘTIINȚIFICE

Files in This Item:
File Description SizeFormat 
EXPERIMENTAL_MYOCADIAL_INFARCTION_AND_INTERLEUKINE_6_MODIFICATIONS.pdf435.8 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback